Search filters

List of works by Scott Rodig

ATIM-32. PERSONALIZED NEOANTIGEN-TARGETING VACCINE GENERATES ROBUST SYSTEMIC AND INTRATUMORAL T CELL RESPONSES IN GLIOBLASTOMA (GBM) PATIENTS

Aspirin Use and Colorectal Cancer Survival According to Tumor CD274 (Programmed Cell Death 1 Ligand 1) Expression Status.

scientific article

Clinical and translational studies of a phase II trial of the novel oral Akt inhibitor perifosine in relapsed or relapsed/refractory Waldenstrom's macroglobulinemia

scientific article

Epithelial adhesion molecules can inhibit HIV-1-specific CD8⁺ T-cell functions

scientific article

Immune evasion mediated by PD-L1 on glioblastoma-derived extracellular vesicles.

scientific article

MHC proteins confer differential sensitivity to CTLA-4 and PD-1 blockade in untreated metastatic melanoma

scientific article published on 01 July 2018

Mass cytometry of Hodgkin lymphoma reveals a CD4+ regulatory T-cell-rich and exhausted T-effector microenvironment

scientific article published on 07 June 2018

Neoantigen vaccine generates intratumoral T cell responses in phase Ib glioblastoma trial

scientific article published on 19 December 2018

Outcomes in patients with relapsed or refractory multiple myeloma in a phase I study of everolimus in combination with lenalidomide

scientific article

Preserved function of regulatory T cells in chronic HIV-1 infection despite decreased numbers in blood and tissue

scientific article

Results of a phase 2 trial of the single-agent histone deacetylase inhibitor panobinostat in patients with relapsed/refractory Waldenström macroglobulinemia

scientific article

TIME (Tumor Immunity in the MicroEnvironment) classification based on tumor CD274 (PD-L1) expression status and tumor-infiltrating lymphocytes in colorectal carcinomas

scientific article published on 19 March 2018

Targetable genetic alterations of () drive immunoglobulin expression in diffuse large B cell lymphoma

scientific article published on 01 June 2019

Tumor PDCD1LG2 (PD-L2) Expression and the Lymphocytic Reaction to Colorectal Cancer.

scientific article published on 16 October 2017

Tumour CD274 (PD-L1) expression and T cells in colorectal cancer.

scientific article published on 5 May 2016

Weekly bortezomib in combination with temsirolimus in relapsed or relapsed and refractory multiple myeloma: a multicentre, phase 1/2, open-label, dose-escalation study

scientific article